InvestorsHub Logo
Followers 18
Posts 1054
Boards Moderated 0
Alias Born 12/07/2002

Re: None

Monday, 01/12/2004 11:57:24 PM

Monday, January 12, 2004 11:57:24 PM

Post# of 82595
By contrast Ovanome does a bit better than 75%. From the Paclitaxel response patent we know that: "When considered within the context of a complex (multifactorial) framework, about 98% of the variability in patient response is explained."